Optical Coherence Tomography (OCT) Market By Type (Catheter-based OCT, Handheld OCT Devices, Tabletop OCT Devices), By Application (Ophthalmology, Cardiovascular, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Optical Coherence Tomography (OCT) Market

The Optical Coherence Tomography (OCT) Market is likely to experience a significant growth rate of 8.6% from 2022-2031 owing to increasing market demand Handheld OCT Devices segment–

Optical coherence tomography (OCT) is a non-invasive imaging technique that uses light waves to produce high-resolution, cross-sectional images of biological tissues. OCT is commonly used in ophthalmology to visualize the retina and diagnose various retinal diseases, including macular degeneration, diabetic retinopathy, and glaucoma. In addition, OCT devices are also used in other medical specialties, such as cardiology, and dermatology, to visualize internal structures and diagnose various conditions.

Key factors driving the growth of the optical coherence tomography (OCT) market are increasing prevalence of eye diseases and technological advancements for development of portable OCT device. The rising prevalence of eye diseases, such as age-related macular degeneration, diabetic retinopathy, and glaucoma, is one of the major drivers of the OCT market. For instance, according to report of Centers for Disease Control and Prevention 2021, stated that, in U.S., 19.8 million people suffered from age-related macular degeneration and 20.5 million from cataract in 2020, resulting in demand of optical coherence tomography (OCT), thereby is anticipated to contribute to growth of market. 

Moreover, rise in adoption of OCT in various disease diagnosis is expected to drive the growth of market. In China, rise in adoption of optical coherence tomography (OCT) devices for diagnosis of many eyes related disorders is observed, which is expected to drive the growth of market. For instance, according to article published in National Library of Medicine 2020, stated that, in China, ENT Hospital of Fudan University (EENT Hospital) and Shanghai Tenth People's Hospital (TENTH Hospital) used optical coherence tomography (OCT) to identify pathologic retinal cases and concluded optical coherence tomography to be effective in retinal disorders screening.

Further, at-home disease monitoring OCT devices are also available and may be more cost-effective for monitoring patients at high-risk of developing eye disorders such as neovascular AMD. In addition, efficiencies of automated systems, such as binocular OCT, which have the potential of reducing cost, increasing quality of data, and introducing novel applications of OCT that can revolutionize many aspects of the eye diagnosis are expected to drive growth of market. In addition, aging population is more susceptible to eye diseases, driving the demand for OCT devices for early detection and treatment of age-related eye diseases is expected to increase. 

Further, increase in awareness by government regarding use of optical coherence tomography for eye diagnosis is expected to fuel the growth of market. For instance, according to report Canadian Ophthalmological Society 2020, stated that, it has developed ‘OCTcases platform’ where medical students, optometry students, residents, and eye care professionals to upgrade their skills in interpreting optical coherence tomography scans. Thus, such initiatives and awareness regarding optical coherence tomography is expected to fuel the growth of the market

The market also offers growth opportunities to the key players in the market.  Many developing regions such India and Brazil offer lucrative opportunities to key players of optical coherence tomography (OCT) market owing to high population base, increase in demand of advanced and portable OCT device for disease diagnosis and increase in healthcare spending. 

The global optical coherence tomography market is segmented into type, technology, application, and region. By type, the market is categorized into catheter-based OCT devices, handheld OCT devices and tabletop OCT devices. By application, the market is categorized into ophthalmology, cardiovascular, and others. By end user, the market is categorized into hospitals, clinics and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the study include Abbott Laboratories, Carl Zeiss Meditec Group, Danaher Corporation (Leica Microsystems), Metall Zug AG (HAAG-STREIT GROUP), Michelson Diagnostics Ltd., NIDEK CO., LTD, Novacam Technologies, Inc., OPTOPOL Technology Sp. z o.o., Thorlabs, Inc and Topcon Corporation. The players in the market have been actively engaged in the adoption various strategies such product launch, product approval, product development acquisition to remain competitive and gain advantage over the competitors in the market. For instance, in April 2019, Carl Zeiss Meditec AG launched the first dual-speed Swept-Source OCT/OCTA that will now scan at 200kHz, in addition to 100kHz, providing doctors a deeper and more detailed view into the retina enabling visualization options for various diseases.

Key Market Insights (Updated)

• On the basis of type, the handheld OCT device segment was highest contributor to the market in 2021.

• On the basis of application, the ophthalmology segment dominated the market in terms of revenue in 2021. However, others segment is anticipated to grow at the highest CAGR during the forecast period.

• On the basis of end user, the hospitals segment accounted for largest share in terms of revenue in 2021.

• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

Optical coherence tomography (OCT) is a revolutionizing in-vivo imaging technique for addressing medical needs in early diagnosis and effective disease management. OCT is rapid, safe, and is increasingly being recognized as the gold standard for diagnosis of retinal disease. The potential of OCT in many other applications is currently being explored, such as in developmental biology, skin cancer diagnostics, vulnerable plaque detection in cardiology, esophageal diagnostics and a number of other applications within oncology. Optical coherence tomography is a micrometer-scale imaging modality that permits label-free, cross-sectional imaging of biological tissue microstructure using tissue backscattering properties. It typically uses light in the near-infrared spectral range which has a penetration depth of several hundred microns in tissue.

The driving factors for optical coherence tomography market are increase in the number of patients suffering from eye disorders, rise in geriatric population and increase in awareness about advanced diagnostic techniques such optical coherence tomography and its applications. The rise in number of eye disorders such as cataracts, glaucoma, age-related macular degeneration, which is primary cause of vision loss, results in demand for advanced diagnostic technique such as optical coherence tomography, thus is predicted to fuel the growth of market. 

For instance, according to report of World Health Organization 2022, stated that, globally 94 million people suffered from cataract and 7.7 million from glaucoma in 2021, thus increase in the patient population suffering from cataracts and glaucoma is expected to boost the demand for OCT devices, thereby driving the growth of market. Further, rise in awareness and adoption of optical coherence tomography (OCT) for diagnosis of eye diseases and cancers are expected to drive the growth of market.

However, high cost of optical coherence tomography (OCT) devices is a factor which restrains the growth of market. In addition, the absence of favorable reimbursement policies is also expected to hamper the growth of the market. The global optical coherence tomography market is segmented into type, technology, application, and region. By type, the market is categorized into catheter-based OCT devices, handheld OCT devices and tabletop OCT devices. By application, the market is categorized into ophthalmology, cardiovascular, and others. By end user, the market is categorized into hospitals, clinics and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global optical coherence tomography market are Abbott Laboratories, Carl Zeiss Meditec Group, Danaher Corporation (Leica Microsystems), Metall Zug AG (HAAG-STREIT GROUP), Michelson Diagnostics Ltd., NIDEK CO., LTD, Novacam Technologies, Inc., OPTOPOL Technology Sp. z o.o., Thorlabs, Inc and Topcon Corporation.

 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the optical coherence tomography (oct) market analysis from 2021 to 2031 to identify the prevailing optical coherence tomography (oct) market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the optical coherence tomography (oct) market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global optical coherence tomography (oct) market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Topcon Corporatio

Scope of Optical Coherence Tomography (OCT) Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of ophthalmic disorders

3.4.1.2. Rising use of optical coherence tomography (OCT) in other clinical fields

3.4.1.3. Technological advancements in optical coherence tomography (OCT)

3.4.2. Restraints

3.4.2.1. High cost of Equipment

3.4.2.2. Skilled person required to operate optical coherence tomography (OCT)

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Catheter-based OCT

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Handheld OCT Devices

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Tabletop OCT Devices

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Ophthalmology

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Cardiovascular

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Clinics

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Type

7.2.3. Market size and forecast, by Application

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Type

7.2.5.1.3. Market size and forecast, by Application

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Type

7.2.5.2.3. Market size and forecast, by Application

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Type

7.2.5.3.3. Market size and forecast, by Application

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Type

7.3.3. Market size and forecast, by Application

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Type

7.3.5.1.3. Market size and forecast, by Application

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Type

7.3.5.2.3. Market size and forecast, by Application

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Type

7.3.5.3.3. Market size and forecast, by Application

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Type

7.3.5.4.3. Market size and forecast, by Application

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Type

7.3.5.5.3. Market size and forecast, by Application

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Type

7.3.5.6.3. Market size and forecast, by Application

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Type

7.4.3. Market size and forecast, by Application

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Type

7.4.5.1.3. Market size and forecast, by Application

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Type

7.4.5.2.3. Market size and forecast, by Application

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Type

7.4.5.3.3. Market size and forecast, by Application

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. Australia

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Type

7.4.5.4.3. Market size and forecast, by Application

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Type

7.4.5.5.3. Market size and forecast, by Application

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Type

7.4.5.6.3. Market size and forecast, by Application

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Type

7.5.3. Market size and forecast, by Application

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Type

7.5.5.1.3. Market size and forecast, by Application

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Type

7.5.5.2.3. Market size and forecast, by Application

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Type

7.5.5.3.3. Market size and forecast, by Application

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Type

7.5.5.4.3. Market size and forecast, by Application

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Carl Zeiss Meditec AG

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.1.7. Key strategic moves and developments

9.2. Michelson Diagnostics Ltd.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Key strategic moves and developments

9.3. NIDEK CO., LTD

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.3.7. Key strategic moves and developments

9.4. Novacam Technologies, Inc.

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. OPTOPOL Technology Sp. z o.o.

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. Thorlabs, Inc

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.6. Key strategic moves and developments

9.7. Metall Zug AG

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.7.6. Business performance

9.7.7. Key strategic moves and developments

9.8. Topcon Corporation

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. Abbott Laboratories

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. Danaher Corporation

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 02. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CATHETER-BASED OCT, BY REGION, 2021-2031 ($MILLION)

TABLE 03. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR HANDHELD OCT DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 04. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR TABLETOP OCT DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 05. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 06. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OPHTHALMOLOGY, BY REGION, 2021-2031 ($MILLION)

TABLE 07. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CARDIOVASCULAR, BY REGION, 2021-2031 ($MILLION)

TABLE 08. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 09. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 10. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 11. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CLINICS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 14. NORTH AMERICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 15. NORTH AMERICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 16. NORTH AMERICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 17. NORTH AMERICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 18. U.S. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 19. U.S. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 20. U.S. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 21. CANADA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 22. CANADA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 23. CANADA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 24. MEXICO OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 25. MEXICO OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 26. MEXICO OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 28. EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 29. EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 30. EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 31. GERMANY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 32. GERMANY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 33. GERMANY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 34. FRANCE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 35. FRANCE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 36. FRANCE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. UK OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 38. UK OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 39. UK OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 40. ITALY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 41. ITALY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 42. ITALY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 43. SPAIN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 44. SPAIN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 45. SPAIN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. REST OF EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 47. REST OF EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 48. REST OF EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 49. ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 50. ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 53. JAPAN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 54. JAPAN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 55. JAPAN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 56. CHINA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 57. CHINA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 58. CHINA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. INDIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 60. INDIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 61. INDIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 62. AUSTRALIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 63. AUSTRALIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 64. AUSTRALIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 65. SOUTH KOREA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 66. SOUTH KOREA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 67. SOUTH KOREA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 68. REST OF ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 69. REST OF ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 71. LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 72. LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 73. LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 74. LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 75. BRAZIL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 76. BRAZIL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 77. BRAZIL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 78. SAUDI ARABIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 79. SAUDI ARABIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 80. SAUDI ARABIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 81. SOUTH AFRICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 82. SOUTH AFRICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 83. SOUTH AFRICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 84. REST OF LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 85. REST OF LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 86. REST OF LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 87. CARL ZEISS MEDITEC AG: KEY EXECUTIVES

TABLE 88. CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT

TABLE 89. CARL ZEISS MEDITEC AG: PRODUCT SEGMENTS

TABLE 90. CARL ZEISS MEDITEC AG: PRODUCT PORTFOLIO

TABLE 91. CARL ZEISS MEDITEC AG: KEY STRATERGIES

TABLE 92. MICHELSON DIAGNOSTICS LTD.: KEY EXECUTIVES

TABLE 93. MICHELSON DIAGNOSTICS LTD.: COMPANY SNAPSHOT

TABLE 94. MICHELSON DIAGNOSTICS LTD.: PRODUCT SEGMENTS

TABLE 95. MICHELSON DIAGNOSTICS LTD.: PRODUCT PORTFOLIO

TABLE 96. MICHELSON DIAGNOSTICS LTD.: KEY STRATERGIES

TABLE 97. NIDEK CO., LTD: KEY EXECUTIVES

TABLE 98. NIDEK CO., LTD: COMPANY SNAPSHOT

TABLE 99. NIDEK CO., LTD: PRODUCT SEGMENTS

TABLE 100. NIDEK CO., LTD: PRODUCT PORTFOLIO

TABLE 101. NIDEK CO., LTD: KEY STRATERGIES

TABLE 102. NOVACAM TECHNOLOGIES, INC.: KEY EXECUTIVES

TABLE 103. NOVACAM TECHNOLOGIES, INC.: COMPANY SNAPSHOT

TABLE 104. NOVACAM TECHNOLOGIES, INC.: PRODUCT SEGMENTS

TABLE 105. NOVACAM TECHNOLOGIES, INC.: PRODUCT PORTFOLIO

TABLE 106. OPTOPOL TECHNOLOGY SP. Z O.O.: KEY EXECUTIVES

TABLE 107. OPTOPOL TECHNOLOGY SP. Z O.O.: COMPANY SNAPSHOT

TABLE 108. OPTOPOL TECHNOLOGY SP. Z O.O.: PRODUCT SEGMENTS

TABLE 109. OPTOPOL TECHNOLOGY SP. Z O.O.: PRODUCT PORTFOLIO

TABLE 110. THORLABS, INC: KEY EXECUTIVES

TABLE 111. THORLABS, INC: COMPANY SNAPSHOT

TABLE 112. THORLABS, INC: PRODUCT SEGMENTS

TABLE 113. THORLABS, INC: PRODUCT PORTFOLIO

TABLE 114. THORLABS, INC: KEY STRATERGIES

TABLE 115. METALL ZUG AG: KEY EXECUTIVES

TABLE 116. METALL ZUG AG: COMPANY SNAPSHOT

TABLE 117. METALL ZUG AG: PRODUCT SEGMENTS

TABLE 118. METALL ZUG AG: PRODUCT PORTFOLIO

TABLE 119. METALL ZUG AG: KEY STRATERGIES

TABLE 120. TOPCON CORPORATION: KEY EXECUTIVES

TABLE 121. TOPCON CORPORATION: COMPANY SNAPSHOT

TABLE 122. TOPCON CORPORATION: PRODUCT SEGMENTS

TABLE 123. TOPCON CORPORATION: PRODUCT PORTFOLIO

TABLE 124. TOPCON CORPORATION: KEY STRATERGIES

TABLE 125. ABBOTT LABORATORIES: KEY EXECUTIVES

TABLE 126. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 127. ABBOTT LABORATORIES: PRODUCT SEGMENTS

TABLE 128. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 129. DANAHER CORPORATION: KEY EXECUTIVES

TABLE 130. DANAHER CORPORATION: COMPANY SNAPSHOT

TABLE 131. DANAHER CORPORATION: PRODUCT SEGMENTS

TABLE 132. DANAHER CORPORATION: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALOPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET

FIGURE 10. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CATHETER-BASED OCT, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR HANDHELD OCT DEVICES, BY COUNTRY 2021-2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR TABLETOP OCT DEVICES, BY COUNTRY 2021-2031(%)

FIGURE 14. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY APPLICATION, 2021(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OPHTHALMOLOGY, BY COUNTRY 2021-2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CARDIOVASCULAR, BY COUNTRY 2021-2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 18. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, BY END USER, 2021(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR CLINICS, BY COUNTRY 2021-2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 22. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET BY REGION, 2021

FIGURE 23. U.S. OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 24. CANADA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 25. MEXICO OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 26. GERMANY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 27. FRANCE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 28. UK OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 29. ITALY OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 30. SPAIN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 31. REST OF EUROPE OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 32. JAPAN OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 33. CHINA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 34. INDIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 35. AUSTRALIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 36. SOUTH KOREA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 37. REST OF ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 38. BRAZIL OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 39. SAUDI ARABIA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 40. SOUTH AFRICA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 41. REST OF LAMEA OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET, 2021-2031 ($MILLION)

FIGURE 42. TOP WINNING STRATEGIES, BY YEAR

FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 46. COMPETITIVE DASHBOARD

FIGURE 47. COMPETITIVE HEATMAP: OPTICAL COHERENCE TOMOGRAPHY (OCT) MARKET

FIGURE 48. TOP PLAYER POSITIONING, 2021

FIGURE 49. CARL ZEISS MEDITEC AG: NET SALES, 2019-2021 ($MILLION)

FIGURE 50. CARL ZEISS MEDITEC AG: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 51. CARL ZEISS MEDITEC AG: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 52. NIDEK CO., LTD: NET SALES, 2019-2021 ($MILLION)

FIGURE 53. NIDEK CO., LTD: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 54. METALL ZUG AG: NET SALES, 2019-2021 ($MILLION)

FIGURE 55. METALL ZUG AG: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 56. METALL ZUG AG: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 57. TOPCON CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 58. TOPCON CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 59. TOPCON CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 60. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)

FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 62. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 63. DANAHER CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 64. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 65. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2021 (%